Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Hemodialysis Patients with Chronic Inflammation
NCT05677555Phase 2Unknown
- Sponsor
- Shamir Medical Center
- Start
- Nov 2022
- Primary completion
- Feb 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in chronic inflammation, sponsored by Shamir Medical Center. Status: unknown.
02
Drugs
colchicine
03
Conditions
chronic inflammation
Beyond the preview
Go deeper on NCT05677555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05677555.